首页> 美国卫生研究院文献>Journal of Cancer Prevention >Clinical Implication of p16 Ki-67 and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on Conization Specimen
【2h】

Clinical Implication of p16 Ki-67 and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on Conization Specimen

机译:p16Ki-67和增生的细胞核抗原在宫颈肿瘤中的表达的临床意义:高度鳞状上皮内病变的诊断准确性的提高和对锥切标本切除缘的预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Cervical intraepithelial neoplasia (CIN) grading is subjective and affected by substantial rates of discordance among pathologists. Although the use of p16INK4a (p16) staining has been proven to improve diagnostic accuracy for high-grade squamous intraepithelial lesion (HSIL), the clinical evidence for use of Ki-67 and proliferating cell nuclear antigen (PCNA) is insufficient to make an independent recommendation for use, alone or in combination. The primary objective was to evaluate clinical utility of Ki-67 and PCNA in combination with p16 in diagnosing HSIL. Also, we assessed the correlation between expressions of three biomarkers and resection margin status of conization specimen.
机译:背景:宫颈上皮内瘤变(CIN)的分级是主观的,并受到病理学家之间相当大的不一致性的影响。尽管已证明使用p16INK4a(p16)染色可提高对高度鳞状上皮内病变(HSIL)的诊断准确性,但使用Ki-67和增殖细胞核抗原(PCNA)的临床证据不足以独立建议单独使用或组合使用。主要目的是评估Ki-67和PC​​NA联合p16在诊断HSIL中的临床实用性。此外,我们评估了三种生物标志物的表达与锥切标本切除边缘状态之间的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号